Sleep disturbances may accelerate neurodegeneration, but whether they cause or result from disease remains unclear. Improving sleep quality could help protect against cognitive decline and brain aging.
Manufacturing roundup: EuroAPI to acquire oligonucleotide maker for $10M+; EU nations face Trulicity shortage
EuroAPI will acquire German-based BianoGMP, a contract manufacturer of oligonucleotides, for €10 million, or $10.9 million. Founded in 2017, BianoGMP mainly focuses on producing oligonucleotides